drugset / Trial / NCT05936567
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.
Timeline
- Start
- 2023-07-31
- Primary completion
- 2025-02-28
- Completion
- 2025-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Povorcitinib | Small molecule | — | — |